Captrust Financial Advisors Sells 190 Shares of Balchem Co. (NASDAQ:BCPC)

Captrust Financial Advisors reduced its stake in Balchem Co. (NASDAQ:BCPC) by 5.1% during the third quarter, HoldingsChannel.com reports. The firm owned 3,558 shares of the basic materials company’s stock after selling 190 shares during the quarter. Captrust Financial Advisors’ holdings in Balchem were worth $626,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Conestoga Capital Advisors LLC lifted its position in Balchem by 1.8% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock valued at $206,900,000 after acquiring an additional 20,360 shares in the last quarter. Geneva Capital Management LLC lifted its position in Balchem by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock valued at $137,257,000 after acquiring an additional 12,750 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Balchem by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock valued at $107,372,000 after acquiring an additional 5,977 shares in the last quarter. FMR LLC lifted its position in Balchem by 944.3% in the 3rd quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock valued at $87,559,000 after acquiring an additional 449,854 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Balchem by 2.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company’s stock valued at $63,707,000 after acquiring an additional 7,562 shares in the last quarter. 87.91% of the stock is owned by institutional investors.

Balchem Price Performance

Shares of BCPC opened at $178.21 on Thursday. The firm has a market cap of $5.79 billion, a PE ratio of 47.91, a P/E/G ratio of 5.30 and a beta of 0.67. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The firm has a fifty day simple moving average of $174.93 and a two-hundred day simple moving average of $168.79. Balchem Co. has a 1-year low of $133.82 and a 1-year high of $186.03.

Balchem Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, January 17th. Stockholders of record on Thursday, December 26th will be paid a $0.87 dividend. This represents a dividend yield of 0.4%. This is a positive change from Balchem’s previous annual dividend of $0.79. The ex-dividend date of this dividend is Thursday, December 26th. Balchem’s dividend payout ratio is 10.75%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on BCPC shares. HC Wainwright upped their price objective on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.